70bigblockdodge
Old Man with a Hat
Keep searching for those magic bullets that hit every time.
Antique polio vaccine the last living polio victim
- Thread starter Turboomni
- Start date
Carmine
Old Man with a Hat
As long as people are not forced to try one of those bullets for something with a 99+% survival rate, the volunteers are free to try whatever they like.
70bigblockdodge
Old Man with a Hat
Yep, I'm pretty sure the polio vaccine will not kill you, but you are free to feed your paranoia, voluntarily of course.
Carmine
Old Man with a Hat
I believe the polio vaccine is well beyond the test phase by now, and the disease itself doesn't offer that 99+% survival rate.
70bigblockdodge
Old Man with a Hat
But it once was, and that was original topic of this thread. The guy in the video survived without the vaccine, better off dead IMO, but a statistic just the same.
Why are you trying to throw Covid gasoline on polio fire?
Carmine
Old Man with a Hat
Aren't these your words?
"With current events of the last year, I hope schools start refusing people who's kids are not vaccinated, fine home school your kids"
I haven't seen much that related to the polio vaccine hesitancy in current events, so it's logical to assume you were referring to Covid.
70bigblockdodge
Old Man with a Hat
Your assumption, I'm speaking of the stupid parents (yes stupid I said it) that are refusing to vaccinate their kids, I'm talking polio, measles, whooping cough, etc.. Yes my words, but no mention of a not fully approved vaccine. Yes there is people that are such conspiracy theorist they believe in not vaccinating their kids, fine just keep them away from my kid.
Sorry for confusion.
It is interesting that we aggressively vaccinate for illnesses that have far less numbers of deaths in absolute terms than covid if those stats are correct.
I can respect anyone waiting for a full approval of the vax before taking it, but I've yet to personally meet anyone with that particular reason for being unvaxed and/or utilizing any safety protocols in the meantime.
I can respect anyone waiting for a full approval of the vax before taking it, but I've yet to personally meet anyone with that particular reason for being unvaxed and/or utilizing any safety protocols in the meantime.
Mike Parker
Active Member
Phizer FDA approved. Everyone can roll up there sleeve and feel comfortable and safe getting the vaccine. Enjoy
MrMoparCHP
Old Man with a Hat
This has nothing to do with paranoia, most people that are not getting the vaccine aren't by choice, not fear. It is statements like this that turn threads political. Saying that someone is paranoid to get the vaccine is essentially shamming them. To me its like having tornado insurance in California, just don't need it.
Alan
Xenon
Senior Member
"The National Weather Service has confirmed two tornadoes touched down in Central California, north of Chico on January 6th. ...
A tornado warning was issued by the Sacramento National Weather Service. So far, 10 tornadoes have been reported in the U.S. in 2021.Jan 19, 2021"
A tornado warning was issued by the Sacramento National Weather Service. So far, 10 tornadoes have been reported in the U.S. in 2021.Jan 19, 2021"
Slap Stick
Active Member
Because you dont have the full story.
It's been used for malaria for decades.
Mike66Chryslers
Senior Member
Malaria is caused by a parasite, not a virus. Very different application. Ivermectin is a drug for killing parasites inside the body, not viruses.
Merck is the company which makes Ivermectin and would stand to profit from its use. They issued a statement that there is no scientific basis for, nor evidence of, the drug's effectiveness on Covid, and to not use it for this purpose.
Merck Statement on Ivermectin use During the COVID-19 Pandemic - Merck.com
patrick66
Old Man with a Hat
Nice try. The Pfizer jab has NOT been approved, and won't be until mid-2023. All you lab rats out there, enjoy!
FDA Approves First COVID-19 Vaccine Link to the fda.gov site not some junk news site
Dated Aug 23 2021
FDA NEWS RELEASE
FDA Approves First COVID-19 Vaccine
Approval Signifies Key Achievement for Public Health
Dated Aug 23 2021
FDA NEWS RELEASE
FDA Approves First COVID-19 Vaccine
Approval Signifies Key Achievement for Public Health
- Share
- Tweet
- Español
Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.
“The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic. While this and other vaccines have met the FDA’s rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product,” said Acting FDA Commissioner Janet Woodcock, M.D. “While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated. Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S.”
Since Dec. 11, 2020, the Pfizer-BioNTech COVID-19 Vaccine has been available under EUA in individuals 16 years of age and older, and the authorization was expanded to include those 12 through 15 years of age on May 10, 2021. EUAs can be used by the FDA during public health emergencies to provide access to medical products that may be effective in preventing, diagnosing, or treating a disease, provided that the FDA determines that the known and potential benefits of a product, when used to prevent, diagnose, or treat the disease, outweigh the known and potential risks of the product.
FDA-approved vaccines undergo the agency’s standard process for reviewing the quality, safety and effectiveness of medical products. For all vaccines, the FDA evaluates data and information included in the manufacturer’s submission of a biologics license application (BLA). A BLA is a comprehensive document that is submitted to the agency providing very specific requirements. For Comirnaty, the BLA builds on the extensive data and information previously submitted that supported the EUA, such as preclinical and clinical data and information, as well as details of the manufacturing process, vaccine testing results to ensure vaccine quality, and inspections of the sites where the vaccine is made. The agency conducts its own analyses of the information in the BLA to make sure the vaccine is safe and effective and meets the FDA’s standards for approval.
Comirnaty contains messenger RNA (mRNA), a kind of genetic material. The mRNA is used by the body to make a mimic of one of the proteins in the virus that causes COVID-19. The result of a person receiving this vaccine is that their immune system will ultimately react defensively to the virus that causes COVID-19. The mRNA in Comirnaty is only present in the body for a short time and is not incorporated into - nor does it alter - an individual’s genetic material. Comirnaty has the same formulation as the EUA vaccine and is administered as a series of two doses, three weeks apart.
“Our scientific and medical experts conducted an incredibly thorough and thoughtful evaluation of this vaccine. We evaluated scientific data and information included in hundreds of thousands of pages, conducted our own analyses of Comirnaty’s safety and effectiveness, and performed a detailed assessment of the manufacturing processes, including inspections of the manufacturing facilities,” said Peter Marks, M.D., Ph.D., director of FDA’s Center for Biologics Evaluation and Research. “We have not lost sight that the COVID-19 public health crisis continues in the U.S. and that the public is counting on safe and effective vaccines. The public and medical community can be confident that although we approved this vaccine expeditiously, it was fully in keeping with our existing high standards for vaccines in the U.S."
FDA Evaluation of Safety and Effectiveness Data for Approval for 16 Years of Age and Older
The first EUA, issued Dec. 11, for the Pfizer-BioNTech COVID-19 Vaccine for individuals 16 years of age and older was based on safety and effectiveness data from a randomized, controlled, blinded ongoing clinical trial of thousands of individuals.
To support the FDA’s approval decision today, the FDA reviewed updated data from the clinical trial which supported the EUA and included a longer duration of follow-up in a larger clinical trial population.
Specifically, in the FDA’s review for approval, the agency analyzed effectiveness data from approximately 20,000 vaccine and 20,000 placebo recipients ages 16 and older who did not have evidence of the COVID-19 virus infection within a week of receiving the second dose. The safety of Comirnaty was evaluated in approximately 22,000 people who received the vaccine and 22,000 people who received a placebo 16 years of age and older.
Based on results from the clinical trial, the vaccine was 91% effective in preventing COVID-19 disease.
More than half of the clinical trial participants were followed for safety outcomes for at least four months after the second dose. Overall, approximately 12,000 recipients have been followed for at least 6 months.
The most commonly reported side effects by those clinical trial participants who received Comirnaty were pain, redness and swelling at the injection site, fatigue, headache, muscle or joint pain, chills, and fever. The vaccine is effective in preventing COVID-19 and potentially serious outcomes including hospitalization and death.
Additionally, the FDA conducted a rigorous evaluation of the post-authorization safety surveillance data pertaining to myocarditis and pericarditis following administration of the Pfizer-BioNTech COVID-19 Vaccine and has determined that the data demonstrate increased risks, particularly within the seven days following the second dose. The observed risk is higher among males under 40 years of age compared to females and older males. The observed risk is highest in males 12 through 17 years of age. Available data from short-term follow-up suggest that most individuals have had resolution of symptoms. However, some individuals required intensive care support. Information is not yet available about potential long-term health outcomes. The Comirnaty Prescribing Information includes a warning about these risks.
Ongoing Safety Monitoring
The FDA and Centers for Disease Control and Prevention have monitoring systems in place to ensure that any safety concerns continue to be identified and evaluated in a timely manner. In addition, the FDA is requiring the company to conduct postmarketing studies to further assess the risks of myocarditis and pericarditis following vaccination with Comirnaty. These studies will include an evaluation of long-term outcomes among individuals who develop myocarditis following vaccination with Comirnaty. In addition, although not FDA requirements, the company has committed to additional post-marketing safety studies, including conducting a pregnancy registry study to evaluate pregnancy and infant outcomes after receipt of Comirnaty during pregnancy.
The FDA granted this application Priority Review. The approval was granted to BioNTech Manufacturing GmbH.
Related Information###
The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.
Inquiries
Media:
FDA Office of Media Affairs
301-796-4540
Consumer:
888-INFO-FDA
patrick66
Old Man with a Hat
NOT the "approval" they claim. It is in trials until 2023. Don't believe their propaganda.
Television commercials by lawyers in 2025 -
"Did you take the Pfizer "vaccine" for C19? If you did, you may be entitled to substantial compensation."
Of course, most of those people "entitled" will be likely deceased.
Television commercials by lawyers in 2025 -
"Did you take the Pfizer "vaccine" for C19? If you did, you may be entitled to substantial compensation."
Of course, most of those people "entitled" will be likely deceased.
Interesting ,,please elaborate
Where did you specifically get this information ,any links please?
Last edited:
patrick66
Old Man with a Hat
I'd love to, but that will happen later today.
Mike66Chryslers
Senior Member
Is this the testing through 2023 you're talking about?
Fact check: It is standard practice for vaccine safety monitoring to continue after approval
"VERDICT: Missing context. It is standard procedure for safety monitoring to continue after vaccines have been approved for use."
To follow-up on @Turboomni 's statement in the original post on this thread, "I am sure the science of vaccines is much better today than 60+years ago": Based on the results so far, experts expect that all future vaccines will be based on mRNA technology.
'It's game over. It's mRNA or nothing' :Expert on vaccines
From what I have read elsewhere, there are much lower incidents of allergic reactions to mRNA vaccines compared to previous "viral vector technology" vaccines because they don't contain actual virus. So there are fewer legitimate medical reasons not to get an mRNA vaccine. It's also not possible for a manufacturer to screw-up and incorporate live virus into an mRNA vaccine which could infect the patient with the disease. That did happen once with Polio vaccine.
67Monaco
Old Man with a Hat
We haven't met but I'm one of those. Being the sole source of income for my family, if something happens to me under "emergency use" my family would have no recourse. None. They passed additional indemnification for the vaccine companies before they started this the jabs, and since none of them were FDA approved they would have no access to the VICP. So yes I waited until the Pfizer shot was approved as my company (a BCBS company) is mandating vaccination by Nov 1, even though we're 95% (as number of employees) remote. Else no I wouldn't be getting the shot until complete testing had completed.
As for my kids, they're 10 years old and 20 months, they'll stick with the traditional vaccines. They also regularly eat and come in contact with things that would drive a germaphobe through the roof. All in an effort to build their natural immune system. Covid juice, no they won't be getting that for quite a few years if at all, mandates be damned.
Similar threads
